Project Number ARUK-DC2017-3 Agency/Funding Organization Alzheimer's Research UK Funding Year 2017 View Full Project Details for Development of new ATF6/DREAM PPI inhibitors for the treatment of cognitive impairment in AD Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) i. Proteostasis/Proteinopathies Researcher and Organization Principal Investigator Jose Naranjo Principal Investigator First Name Jose Principal Investigator Last Name Naranjo Awardee Organization (Spain, Europe) Spanish National Center for Biotechnology Contact PI Country Spain Project Detail FY Overall Cost $47,601 Funding Organization Agency/Funding Organization Alzheimer's Research UK Funding Organization Country United Kingdom
